查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1285860

C反應蛋白檢測市場 - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測

C-reactive Protein Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 194 Pages | 商品交期: 2-10個工作天內

價格

C-反應蛋白檢測市場- 報告範圍

TMR關於全球C-反應蛋白測試市場的報告研究了過去以及當前的成長趨勢和機會，以獲得對2023年至2031年預測期間市場指標的寶貴見解。報告提供了2017-2031年期間全球C-反應蛋白檢測市場的收入，考慮到2023年為基準年，2031年為預測年。報告還提供了2023年至2031年全球C-反應蛋白檢測市場的複合年成長率（CAGR %）。

該報告是在廣泛研究後編寫的。一級研究涉及大部分的研究工作，其中分析師與關鍵意見領袖、行業領袖和意見製造者進行了訪談。二級研究包括參考主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解等離子體材料市場。

該報告深入研究了全球等離子體材料市場的競爭格局。在全球C-反應蛋白測試市場運作的主要參與者已被確定，其中每一個都在各種屬性方面進行了分析。公司概況、財務狀況、近期發展和SWOT是本報告對全球C-反應蛋白檢測市場參與者的屬性描述。

目錄

第一章：前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 研究重點

第二章：假設和研究方法

第三章：執行摘要：全球市場

第四章：市場概述

  • 簡介
    • 細分市場的定義
    • 行業演變/發展
  • 市場概況
  • 市場動態
    • 驅動力
    • 限制因素
    • 機會
  • 2017-2031年全球市場分析與預測

第五章：關鍵洞察力

  • 市場概況
  • 主要產品/品牌分析
  • 管線分析
  • COVID-19大流行對行業的影響

第六章：全球市場分析與預測：按測試類型分類

  • 介紹和定義
  • 主要發現/發展
  • 市場價值預測：按測試類型，2017-2031年
    • 標準C反應蛋白測試
    • 高敏C反應蛋白（hs-CRP）測試
  • 市場吸引力分析：按測試類型

第七章：全球市場分析和預測：按檢測類型分類

  • 介紹和定義
  • 主要研究結果/發展
  • 市場價值預測：按檢測類型，2017-2031年
    • 酶聯免疫法
    • 免疫比濁法
    • 免疫層析法
    • 免疫螢光法
    • 其他檢測方法
  • 市場吸引力分析：按檢測類型分類

第八章：全球市場分析與預測：按適應症分類

  • 介紹和定義
  • 主要研究結果/發展
  • 市場價值預測：按適應症分類，2017-2031年
    • 心臟病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市場吸引力分析：按適應症分類

第九章：全球市場分析與預測：按終端用戶分類

  • 介紹和定義
  • 主要研究結果/發展
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院聯合實驗室
    • 獨立診斷實驗室
    • 其他
  • 市場吸引力分析：按終端用戶分類

第十章：全球市場分析與預測：按地區分類

  • 主要發現
  • 市場價值預測：按地區，2017-2031年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第11章：北美洲市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按測試類型，2017-2031年
    • 標準C反應蛋白測試
    • 高敏C反應蛋白（hs-CRP）測試
  • 市場價值預測：按化驗類型，2017-2031年
    • 酶聯免疫法
    • 免疫比濁法
    • 免疫層析法
    • 免疫螢光法
    • 其他
  • 市場價值預測：2017-2031年，按適應症分類
    • 心臟病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院聯合實驗室
    • 獨立診斷實驗室
    • 其他
  • 市場價值預測：按國家分類，2017-2031年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按測試類型
    • 按化驗類型
    • 按適應症分類
    • 按終端用戶分類
    • 按國家分類

第12章：歐洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按測試類型，2017-2031年
    • 標準C反應蛋白測試
    • 高敏C反應蛋白（hs-CRP）測試
  • 市場價值預測：按化驗類型，2017-2031年
    • 酶聯免疫法
    • 免疫比濁法
    • 免疫層析法
    • 免疫螢光法
    • 其他
  • 市場價值預測：2017-2031年，按適應症分類
    • 心臟病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院聯合實驗室
    • 獨立診斷實驗室
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 市場吸引力分析
    • 按測試類型
    • 按化驗類型
    • 按適應症分類
    • 按終端用戶
    • 按國家/次區域分類

第13章：亞太地區市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按測試類型，2017-2031年
    • 標準C反應蛋白測試
    • 高敏C反應蛋白（hs-CRP）測試
  • 市場價值預測：按化驗類型，2017-2031年
    • 酶聯免疫法
    • 免疫比濁法
    • 免疫層析法
    • 免疫螢光法
    • 其他
  • 市場價值預測：2017-2031年，按適應症分類
    • 心臟病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院聯合實驗室
    • 獨立診斷實驗室
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 中國
    • 日本
    • 印度
    • 澳大利亞和新西蘭
    • 亞太其他地區
  • 市場吸引力分析
    • 按測試類型
    • 按檢測類型
    • 按適應症分類
    • 按終端用戶
    • 按國家/次區域分類

第十四章：拉美市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按測試類型，2017-2031年
    • 標準C反應蛋白測試
    • 高敏C反應蛋白（hs-CRP）測試
  • 市場價值預測：按化驗類型，2017-2031年
    • 酶聯免疫法
    • 免疫比濁法
    • 免疫層析法
    • 免疫螢光法
    • 其他
  • 市場價值預測：2017-2031年，按適應症分類
    • 心臟病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院聯合實驗室
    • 獨立診斷實驗室
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 巴西
    • 墨西哥
    • 拉美其他地區
  • 市場吸引力分析
    • 按測試類型
    • 按檢測類型
    • 按適應症分類
    • 按終端用戶
    • 按國家/次區域分類

第15章：中東和非洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按測試類型，2017-2031年
    • 標準C反應蛋白測試
    • 高敏C反應蛋白（hs-CRP）測試
  • 市場價值預測：按化驗類型，2017-2031年
    • 酶聯免疫法
    • 免疫比濁法
    • 免疫層析法
    • 免疫螢光法
    • 其他
  • 市場價值預測：2017-2031年，按適應症分類
    • 心臟病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市場價值預測：按終端用戶，2017-2031年
    • 醫院聯合實驗室
    • 獨立診斷實驗室
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 海灣合作委員會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按測試類型
    • 按檢測類型
    • 按適應症分類
    • 按終端用戶
    • 按國家/次區域分類

第16章：競爭格局

  • 市場參與者- 競爭矩陣（按公司層級和規模）。
  • 市場佔有率分析：按公司分類(2022)
  • 公司簡介
    • Agilent Technologies, Inc.
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Creative Diagnostics
    • DxGen Corp
    • CTK Biotech, Inc.
    • Getein Biotech, Inc.
    • Goldsite Diagnostics, Inc.
    • OptiBio Co., Ltd.
    • Nanjing Vazyme Biotech Co., Ltd.
Product Code: TMRGL1899

C-Reactive Protein Testing Market - Scope of Report

TMR's report on the global C-Reactive Protein Testing Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global C-Reactive Protein Testing Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global C-Reactive Protein Testing Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the C-Reactive Protein Testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global C-Reactive Protein Testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global C-Reactive Protein Testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global C-Reactive Protein Testing market.

The report delves into the competitive landscape of the global C-Reactive Protein Testing market. Key players operating in the global C-Reactive Protein Testing Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global C-Reactive Protein Testing Market profiled in this report.

Key Questions Answered in Global C-Reactive Protein Testing Market Report:

  • What is the sales/revenue generated by C-Reactive Protein Testing across all regions during the forecast period?
  • What are the opportunities in the global C-Reactive Protein Testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

C-Reactive Protein Testing Market - Research Objectives and Research Approach

The comprehensive report on the global C-Reactive Protein Testing Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global C-Reactive Protein Testing Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global C-Reactive Protein Testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global C-reactive Protein Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global C-reactive Protein Testing Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Overview of C-reactive Protein Testing Market
  • 5.2. Key Product/ Brand Analysis
  • 5.3. Pipeline Analysis
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global C-reactive Protein Testing Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Test Type, 2017-2031
    • 6.3.1. Standard C-reactive Protein Test
    • 6.3.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 6.4. Market Attractiveness Analysis, by Test Type

7. Global C-reactive Protein Testing Market Analysis and Forecast, by Type of Assay

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 7.3.1. ELISA
    • 7.3.2. Immunoturbidimetry
    • 7.3.3. Immuno-chromatography
    • 7.3.4. Immunofluorescence
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Type of Assay

8. Global C-reactive Protein Testing Market Analysis and Forecasts, by Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Indication, 2017-2031
    • 8.3.1. Heart Diseases
    • 8.3.2. Inflammatory Diseases
    • 8.3.3. Infectious Diseases
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Indication

9. Global C-reactive Protein Testing Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospital Associated Laboratories
    • 9.3.2. Independent Diagnostic Laboratories
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global C-reactive Protein Testing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America C-reactive Protein Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Test Type, 2017-2031
    • 11.2.1. Standard C-reactive Protein Test
    • 11.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 11.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 11.3.1. ELISA
    • 11.3.2. Immunoturbidimetry
    • 11.3.3. Immuno-chromatography
    • 11.3.4. Immunofluorescence
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Indication, 2017-2031
    • 11.4.1. Heart Diseases
    • 11.4.2. Inflammatory Diseases
    • 11.4.3. Infectious Diseases
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospital Associated Laboratories
    • 11.5.2. Independent Diagnostic Laboratories
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Test Type
    • 11.7.2. By Type of Assay
    • 11.7.3. By Indication
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe C-reactive Protein Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Test Type, 2017-2031
    • 12.2.1. Standard C-reactive Protein Test
    • 12.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 12.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 12.3.1. ELISA
    • 12.3.2. Immunoturbidimetry
    • 12.3.3. Immuno-chromatography
    • 12.3.4. Immunofluorescence
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Indication, 2017-2031
    • 12.4.1. Heart Diseases
    • 12.4.2. Inflammatory Diseases
    • 12.4.3. Infectious Diseases
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospital Associated Laboratories
    • 12.5.2. Independent Diagnostic Laboratories
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Test Type
    • 12.7.2. By Type of Assay
    • 12.7.3. By Indication
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific C-reactive Protein Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Test Type, 2017-2031
    • 13.2.1. Standard C-reactive Protein Test
    • 13.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 13.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 13.3.1. ELISA
    • 13.3.2. Immunoturbidimetry
    • 13.3.3. Immuno-chromatography
    • 13.3.4. Immunofluorescence
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Indication, 2017-2031
    • 13.4.1. Heart Diseases
    • 13.4.2. Inflammatory Diseases
    • 13.4.3. Infectious Diseases
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospital Associated Laboratories
    • 13.5.2. Independent Diagnostic Laboratories
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Test Type
    • 13.7.2. By Type of Assay
    • 13.7.3. By Indication
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America C-reactive Protein Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Test Type, 2017-2031
    • 14.2.1. Standard C-reactive Protein Test
    • 14.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 14.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 14.3.1. ELISA
    • 14.3.2. Immunoturbidimetry
    • 14.3.3. Immuno-chromatography
    • 14.3.4. Immunofluorescence
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Indication, 2017-2031
    • 14.4.1. Heart Diseases
    • 14.4.2. Inflammatory Diseases
    • 14.4.3. Infectious Diseases
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospital Associated Laboratories
    • 14.5.2. Independent Diagnostic Laboratories
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Test Type
    • 14.7.2. By Type of Assay
    • 14.7.3. By Indication
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa C-reactive Protein Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Test Type, 2017-2031
    • 15.2.1. Standard C-reactive Protein Test
    • 15.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 15.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 15.3.1. ELISA
    • 15.3.2. Immunoturbidimetry
    • 15.3.3. Immuno-chromatography
    • 15.3.4. Immunofluorescence
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Indication, 2017-2031
    • 15.4.1. Heart Diseases
    • 15.4.2. Inflammatory Diseases
    • 15.4.3. Infectious Diseases
    • 15.4.4. Others
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospital Associated Laboratories
    • 15.5.2. Independent Diagnostic Laboratories
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Test Type
    • 15.7.2. By Type of Assay
    • 15.7.3. By Indication
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Agilent Technologies, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Laboratory Corporation of America Holdings
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Thermo Fisher Scientific
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Abbott Laboratories
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. F. Hoffmann-La Roche Ltd.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Creative Diagnostics
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. DxGen Corp
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. CTK Biotech, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Getein Biotech, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Goldsite Diagnostics, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. OptiBio Co., Ltd.
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Nanjing Vazyme Biotech Co., Ltd.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview

List of Tables

  • Table 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 02: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 03: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 04: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 08: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 09: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 10: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 13: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 14: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 15: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 18: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 19: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 20: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 23: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 24: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 25: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 28: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 29: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 30: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global C-reactive Protein Testing Market Value Share, by Test Type, 2022
  • Figure 03: Global C-reactive Protein Testing Market Value Share, by Types of Assay, 2022
  • Figure 04: Global C-reactive Protein Testing Market Value Share, by Indication, 2022
  • Figure 05: Global C-reactive Protein Testing Market Value Share, by End-user, 2022
  • Figure 06: Global C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 07: Global C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 08: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Standard C-reactive Protein Test , 2017-2031
  • Figure 09: Global C-reactive Protein Testing Market Revenue (US$ Mn), by High-sensitivity C-reactive Protein (hs-CRP) Test, 2017-2031
  • Figure 10: Global C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 11: Global C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 12: Global C-reactive Protein Testing Market Value (US$ Mn), by ELISA, 2017-2031
  • Figure 13: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunoturbidimetry, 2017-2031
  • Figure 14: Global C-reactive Protein Testing Market Value (US$ Mn), by Irreversible Immuno-chromatography, 2017-2031
  • Figure 15: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunofluorescence, 2017-2031
  • Figure 16: Global C-reactive Protein Testing Market Value (US$ Mn), by Others, 2017-2031
  • Figure 17: Global C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 18: Global C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 19: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Heart Diseases, 2017-2031
  • Figure 20: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Inflammatory Diseases, 2017-2031
  • Figure 21: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Infectious Diseases, 2017-2031
  • Figure 22: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 23: Global C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Hospital Associated Laboratories, 2017-2031
  • Figure 26: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Independent Diagnostic Laboratories, 2017-2031
  • Figure 27: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 28: Global C-reactive Protein Testing Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 29: Global C-reactive Protein Testing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 30: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 31: North America C-reactive Protein Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 32: North America C-reactive Protein Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 33: North America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 34: North America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 35: North America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 36: North America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 37: North America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 38: North America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 39: North America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Europe C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 43: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Europe C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 45: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 46: Europe C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 47: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 48: Europe C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 49: Europe C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 50: Europe C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Europe C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 53: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 56: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 57: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 58: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 59: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 60: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 61: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 63: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 64: Latin America C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 65: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 66: Latin America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 67: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 68: Latin America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 69: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 70: Latin America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 71: Latin America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 72: Latin America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 74: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 75: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 76: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 77: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 78: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 79: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 80: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay 2023-2031
  • Figure 81: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 82: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 83: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 84: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 85: Global C-reactive Protein Testing Market Share Analysis By Company (2022)